For patients with stage I seminoma, a germ cell tumor of the testicle or other extragonadal locations, post-orchiectomy surveillance with magnetic resonance imaging (MRI) is noninferior to computed tomography (CT) imaging and avoids excess radiation, according to results of the phase 3 Trial of Imaging and Surveillance in Seminoma Testis (TRISST) presented this past weekend at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium. "Survival after orchiectomy in stage I...